Join
Live feed
·
INSIDERFilingvia Quantisnow
Skye Bioscience Inc. logo

Amendment: Chief Financial Officer Arsenault Kaitlyn sold $215,754 worth of shares (43,216 units at $4.99), decreasing direct ownership by 21% to 167,522 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SKYE· Skye Bioscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SKYE (Skye Bioscience Inc.) and more on Quantisnow.